Duration of Follow-Up Counselling on Smoking Cessation Outcomes
NCT ID: NCT01893502
Last Updated: 2017-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2013-06-30
2016-03-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telephone Counseling for Tobacco Cessation
NCT01489579
Telephone Counseling and the Distribution of Nicotine Patches to Smokers
NCT00851357
Telephone-Delivered Interventions for Smoking Cessation
NCT02421991
Identifying Treatments to Motivate Smokers to Quit
NCT01122238
Overcoming Nicotine Dependence to Enable Quitting
NCT05513872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Participants will receive weekly proactive and live telephone counselling from Quitline (run by the Health Promotion Board) for one month
Telephone counselling from Quitline
Group 2
Participants will receive weekly proactive and live telephone counselling from Quitline (run by the Health Promotion Board) for six months
Telephone counselling from Quitline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telephone counselling from Quitline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Subjects who are participating or will be participating in other smoking cessation programs within the next six months
* Subjects who are currently using smoking cessation medications
* Subjects who cannot be followed up for at least six months, for instance, subjects who would be resigning and going overseas within the next six months
* Subjects with language limitations that would impede completion of self-administered questionnaires
* Subjects who are difficult to communicate with over the telephone (e.g. having speech or hearing problems)
* Subjects with cognitive impairments that would impede counselling and follow-up
* Subjects with no telephone number
* Subjects who are too sick to receive smoking cessation counselling
* Subjects with limited life expectancy (e.g. metastatic cancer)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University Hospital, Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Medicine
Dr. See Kay Choong
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kay C See, MBBS
Role: PRINCIPAL_INVESTIGATOR
National University Hospital, Singapore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National University Hospital
Singapore, Singapore, Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/00057
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.